Filing Details
- Accession Number:
- 0001415889-21-002817
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-04 16:15:17
- Reporting Period:
- 2021-06-02
- Accepted Time:
- 2021-06-04 16:15:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1821323 | Sigilon Therapeutics Inc. | SGTX | Pharmaceutical Preparations (2834) | 474005543 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1834111 | Griffith Daniel Anderson | C/O Sigilon Therapeutics, Inc. 100 Binney Street Ste 600 Cambridge MA 02142 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-06-02 | 200,000 | $10.00 | 2,022,222 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
